Bhupendra Prajapati, PhD, is a Professor in the Department of Pharmaceutics at the Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India, and Adjunct Professor at Silpakorn University, Thailand. He has 22 years of academic and research experience and published more than 250 research and review works in international and national journals. He has delivered invited scientific talks at many conferences and seminars worldwide. He authored 150 book chapters in the field of novel drug delivery. He edited 20 books with publishers such as Elsevier, AAP CRC, Wiley, Springer, and Jenny Stanford. He is a reviewer for many high-impact journals and is an editorial board member of several journals as well.Rishabha Malviya, PhD, has 12 years of research experience and is presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has published many papers in reputed national and international journals, for which he received an outstanding reviewer award from Elsevier. He has edited 13 books (Wiley, Springer Nature, CRC Press/Taylor and Francis, Apple Academic Press, River Publisher, Lambert, and OMICS Publishing Group) and authored 15 book chapters. His name has been included in the World Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with B2B industry, Ingredient South Asia. He completed his BPharm at Uttar Pradesh Technical University and MPharm (Pharmaceutics) at Gautam Buddha Technical University, Lucknow Uttar, India.Himanshu Paliwal, PhD, is an Assistant Professor (Research) at the Marwadi University Research Center, Marwadi University, India. He completed his PhD at Bhupal Nobles’ University, Udaipur, and pursued postdoctoral research at the Drug Delivery System Excellence Center, Prince of Songkla University, Thailand. With over nine years of experience in research and academia, Dr. Paliwal has published 32 research and review papers in peer-reviewed journals and contributed 13 book chapters with renowned publishing houses. He is a lifetime member of the Association of Pharmaceutical Teachers of India and has mentored 11 postgraduate research scholars. His current research focuses on lipid-based drug delivery systems and micellar solubilization for treating ocular, pulmonary diseases, and cancer.Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, Greater Noida, Uttar Pradesh, India. Previously, she worked as a research scientist on a project of ICMR at King George Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. Her PhD (Pharmacy) work was in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has authored or edited 14 books (Wiley, CRC Press/Taylor and Francis, River Publisher, IOP Publishing) and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit. She completed both BPharm and MPharm (Pharmacology) at Dr. A.P.J. Abdul Kalam Technical University, Lucknow, India.

• 1. Age-Related Macular Degeneration: Etiology, Pathophysiology, and Stages 2. Risk Factors for Progression of Age-Related Macular Degeneration 3. The Role of Inflammation on Age-Related Macular Degeneration 4. Genetics of Age-Related Macular Degeneration (AMD): Current Understanding and Clinical Implications 5. Macular Degeneration and Ocular Drug Delivery System: Causes, Symptoms, Diagnosis, and Treatment 6. Imaging and Artificial Intelligence in Diagnosis of Macular Degeneration 7. Biomarkers and Medical Laboratory Testing for Age-Related Macular Degeneration 8. Molecular Pathology-Based Therapeutic Interventions of Macular Degeneration: Unravelling Complexity 9. Nanotechnology: Revolutionizing the Delivery of Drugs to Treat Macular Degeneration 10. Gene Therapies for Age-Related Macular Degeneration 11. Anti-VEGF Therapy for Age-Related Macular Degeneration 12. The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis, and Treatment of Age-Related Macular Degeneration 13. Role of Vitamins and Minerals in Controlling Macular Degeneration 14. Liposome in Targeting Macular Degeneration 15. Current Insights and Future Prospects in Nanoemulsion-Based Delivery Systems for Macular Degeneration 16. Biomaterial-Based Therapeutic Strategies for Macular Degeneration: An Explicative Review 17. Antibody-Based Therapies for Age-Related Macular Degeneration: Challenges and Opportunities 18. Long-Acting Intraocular Delivery Approaches for Biological Therapy of Age-Related Macular Degeneration 19. Implants and Inserts in Diagnosis and Treatment of Macular Degeneration 20. Polysaccharide-Based Formulations in Treatment of Macular Disease 21. Recent Updates in Synthetic and Biological Molecules for Treatment/Therapy of Macular Degeneration Drugs 22. Artificial Intelligence in Macular Degeneration: Detection and Therapy

Bhupendra Prajapati, PhD, is a Professor in the Department of Pharmaceutics at the Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India, and Adjunct Professor at Silpakorn University, Thailand. He has 22 years of academic and research experience and published more than 250 research and review works in international and national journals. He has delivered invited scientific talks at many conferences and seminars worldwide. He authored 150 book chapters in the field of novel drug delivery. He edited 20 books with publishers such as Elsevier, AAP CRC, Wiley, Springer, and Jenny Stanford. He is a reviewer for many high-impact journals and is an editorial board member of several journals as well.Rishabha Malviya, PhD, has 12 years of research experience and is presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has published many papers in reputed national and international journals, for which he received an outstanding reviewer award from Elsevier. He has edited 13 books (Wiley, Springer Nature, CRC Press/Taylor and Francis, Apple Academic Press, River Publisher, Lambert, and OMICS Publishing Group) and authored 15 book chapters. His name has been included in the World Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with B2B industry, Ingredient South Asia. He completed his BPharm at Uttar Pradesh Technical University and MPharm (Pharmaceutics) at Gautam Buddha Technical University, Lucknow Uttar, India.Himanshu Paliwal, PhD, is an Assistant Professor (Research) at the Marwadi University Research Center, Marwadi University, India. He completed his PhD at Bhupal Nobles’ University, Udaipur, and pursued postdoctoral research at the Drug Delivery System Excellence Center, Prince of Songkla University, Thailand. With over nine years of experience in research and academia, Dr. Paliwal has published 32 research and review papers in peer-reviewed journals and contributed 13 book chapters with renowned publishing houses. He is a lifetime member of the Association of Pharmaceutical Teachers of India and has mentored 11 postgraduate research scholars. His current research focuses on lipid-based drug delivery systems and micellar solubilization for treating ocular, pulmonary diseases, and cancer.Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, Greater Noida, Uttar Pradesh, India. Previously, she worked as a research scientist on a project of ICMR at King George Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. Her PhD (Pharmacy) work was in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has authored or edited 14 books (Wiley, CRC Press/Taylor and Francis, River Publisher, IOP Publishing) and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit. She completed both BPharm and MPharm (Pharmacology) at Dr. A.P.J. Abdul Kalam Technical University, Lucknow, India.

• 1. Age-Related Macular Degeneration: Etiology, Pathophysiology, and Stages 2. Risk Factors for Progression of Age-Related Macular Degeneration 3. The Role of Inflammation on Age-Related Macular Degeneration 4. Genetics of Age-Related Macular Degeneration (AMD): Current Understanding and Clinical Implications 5. Macular Degeneration and Ocular Drug Delivery System: Causes, Symptoms, Diagnosis, and Treatment 6. Imaging and Artificial Intelligence in Diagnosis of Macular Degeneration 7. Biomarkers and Medical Laboratory Testing for Age-Related Macular Degeneration 8. Molecular Pathology-Based Therapeutic Interventions of Macular Degeneration: Unravelling Complexity 9. Nanotechnology: Revolutionizing the Delivery of Drugs to Treat Macular Degeneration 10. Gene Therapies for Age-Related Macular Degeneration 11. Anti-VEGF Therapy for Age-Related Macular Degeneration 12. The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis, and Treatment of Age-Related Macular Degeneration 13. Role of Vitamins and Minerals in Controlling Macular Degeneration 14. Liposome in Targeting Macular Degeneration 15. Current Insights and Future Prospects in Nanoemulsion-Based Delivery Systems for Macular Degeneration 16. Biomaterial-Based Therapeutic Strategies for Macular Degeneration: An Explicative Review 17. Antibody-Based Therapies for Age-Related Macular Degeneration: Challenges and Opportunities 18. Long-Acting Intraocular Delivery Approaches for Biological Therapy of Age-Related Macular Degeneration 19. Implants and Inserts in Diagnosis and Treatment of Macular Degeneration 20. Polysaccharide-Based Formulations in Treatment of Macular Disease 21. Recent Updates in Synthetic and Biological Molecules for Treatment/Therapy of Macular Degeneration Drugs 22. Artificial Intelligence in Macular Degeneration: Detection and Therapy

Bhupendra Prajapati, PhD, is a Professor in the Department of Pharmaceutics at the Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India, and Adjunct Professor at Silpakorn University, Thailand. He has 22 years of academic and research experience and published more than 250 research and review works in international and national journals. He has delivered invited scientific talks at many conferences and seminars worldwide. He authored 150 book chapters in the field of novel drug delivery. He edited 20 books with publishers such as Elsevier, AAP CRC, Wiley, Springer, and Jenny Stanford. He is a reviewer for many high-impact journals and is an editorial board member of several journals as well.Rishabha Malviya, PhD, has 12 years of research experience and is presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has published many papers in reputed national and international journals, for which he received an outstanding reviewer award from Elsevier. He has edited 13 books (Wiley, Springer Nature, CRC Press/Taylor and Francis, Apple Academic Press, River Publisher, Lambert, and OMICS Publishing Group) and authored 15 book chapters. His name has been included in the World Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with B2B industry, Ingredient South Asia. He completed his BPharm at Uttar Pradesh Technical University and MPharm (Pharmaceutics) at Gautam Buddha Technical University, Lucknow Uttar, India.Himanshu Paliwal, PhD, is an Assistant Professor (Research) at the Marwadi University Research Center, Marwadi University, India. He completed his PhD at Bhupal Nobles’ University, Udaipur, and pursued postdoctoral research at the Drug Delivery System Excellence Center, Prince of Songkla University, Thailand. With over nine years of experience in research and academia, Dr. Paliwal has published 32 research and review papers in peer-reviewed journals and contributed 13 book chapters with renowned publishing houses. He is a lifetime member of the Association of Pharmaceutical Teachers of India and has mentored 11 postgraduate research scholars. His current research focuses on lipid-based drug delivery systems and micellar solubilization for treating ocular, pulmonary diseases, and cancer.Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, Greater Noida, Uttar Pradesh, India. Previously, she worked as a research scientist on a project of ICMR at King George Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. Her PhD (Pharmacy) work was in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has authored or edited 14 books (Wiley, CRC Press/Taylor and Francis, River Publisher, IOP Publishing) and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit. She completed both BPharm and MPharm (Pharmacology) at Dr. A.P.J. Abdul Kalam Technical University, Lucknow, India.

• 1. Age-Related Macular Degeneration: Etiology, Pathophysiology, and Stages 2. Risk Factors for Progression of Age-Related Macular Degeneration 3. The Role of Inflammation on Age-Related Macular Degeneration 4. Genetics of Age-Related Macular Degeneration (AMD): Current Understanding and Clinical Implications 5. Macular Degeneration and Ocular Drug Delivery System: Causes, Symptoms, Diagnosis, and Treatment 6. Imaging and Artificial Intelligence in Diagnosis of Macular Degeneration 7. Biomarkers and Medical Laboratory Testing for Age-Related Macular Degeneration 8. Molecular Pathology-Based Therapeutic Interventions of Macular Degeneration: Unravelling Complexity 9. Nanotechnology: Revolutionizing the Delivery of Drugs to Treat Macular Degeneration 10. Gene Therapies for Age-Related Macular Degeneration 11. Anti-VEGF Therapy for Age-Related Macular Degeneration 12. The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis, and Treatment of Age-Related Macular Degeneration 13. Role of Vitamins and Minerals in Controlling Macular Degeneration 14. Liposome in Targeting Macular Degeneration 15. Current Insights and Future Prospects in Nanoemulsion-Based Delivery Systems for Macular Degeneration 16. Biomaterial-Based Therapeutic Strategies for Macular Degeneration: An Explicative Review 17. Antibody-Based Therapies for Age-Related Macular Degeneration: Challenges and Opportunities 18. Long-Acting Intraocular Delivery Approaches for Biological Therapy of Age-Related Macular Degeneration 19. Implants and Inserts in Diagnosis and Treatment of Macular Degeneration 20. Polysaccharide-Based Formulations in Treatment of Macular Disease 21. Recent Updates in Synthetic and Biological Molecules for Treatment/Therapy of Macular Degeneration Drugs 22. Artificial Intelligence in Macular Degeneration: Detection and Therapy